Este programa de máster tiene como objetivo principal proporcionar a los licenciados y graduados en ciencias de la salud y ciencias biomédicas las competencias en investigación clínica necesarias para el acceso a los estudios de doctorado
- September - June
- 2790 € + tasas (precio para alumnos de la UE 2016-17)
- Full time
- Spanish / Catalan
- 1 academic year
- 60 ECTS
The main objective of this master's program is to provide graduates and graduates in health sciences and biomedical sciences with the competencies in clinical research necessary for access to doctoral studies.
Clinical Microbiology is experiencing important development, due to improvements in traditional diagnostic techniques, the application of molecular biology methods to the diagnosis and control of infections, and also due to the appearance and spread of emerging and / or re-emerging pathogens. This scenario takes the possibilities and applications of research in microbiology to the first level.
There is a growing demand for students from bachelor's degrees and degrees related to the health sciences and human biology who wish to develop a research career in this field. For this reason, it is necessary to master different techniques used in classical microbiology and combine them with molecular techniques, common to other areas of science. On the other hand, they must be interpreted correctly and in the context of each microorganism and the infections that it causes or in which it participates.
This Master's degree aims to channel interest in this training and offer methodological tools and a favorable environment for the development of doctoral theses in different aspects of microbiology. Among others, emphasis is placed on bacterial chemotherapy, both in the action and in the virulence and defense mechanisms that microorganisms have, in classical and molecular epidemiology and in the diagnosis of community and nosocomial infections. Methodological knowledge of microbiological and molecular biology techniques is also considered important, as well as the study of infectious diseases with their own specificities, such as tuberculosis or parasitic diseases.
The main objective is to provide basic but solid tools to carry out a remarkable doctoral thesis in the field of research on microorganisms that cause infections. We are willing to offer a high-quality master's degree, with content especially aimed at areas of knowledge in which the master's professors are recognized experts.
Three departments from the University of Barcelona and one from the Autonomous University participate in the Master in Clinical Microbiology, as well as the microbiology services or units of the Hospital Clinic, Sant Pau, Bellvitge, Vall d'Hebron, Parc Taulí, Germans Trias i Pujol, the Reference Laboratory of Catalonia, the associated research centers and also the Microbiology Section of the Sant Joan de Deu Hospital.
The specific objectives are to be the basis for developing a thesis, to provide basic training in relevant aspects of research in Clinical Microbiology, to introduce students to research through the completion of a job, to foster an analytical spirit to develop research biomedical skills.
Qualities of Clinical Microbiology Researchers
- They must know principal microorganisms and the techniques to diagnose them and demonstrate their pathogenic and virulence mechanisms, resistance formation and clinical presentation in patients.
- They must have a critical spirit, know how to analyze problems and propose solutions, designing the most appropriate methods.
- They must understand the design of research papers and how to formulate them.
- They must have a strong capacity for teamwork and learn to communicate and publish research results.
Candidates must have an interest in clinical microbiology research and use the knowledge and skills acquired in the master's degree as the basis for a doctoral thesis. The program is aimed at students with a bachelor's or bachelor's degree in health sciences and biomedical areas.
Candidates should complete pre-registration as indicated here.
Orientative tuition prices
2.790 € + taxes.
Price for non-European Union students: 4.920 € + taxes.
Students must take 21 common credits, 21 credits of Master's degree track and 18 credits of research work.
Total 60 ECTS.
Common credits (21 ECTS)
Offered in online and face-to-face format.
- Systems Medicine (6 ECTS)
- Research tools and methodology (6 ECTS)
- Research design and analysis instruments (6 ECTS)
- Bioethics (3 ECTS)
Track credits: Clinical Microbiology (21 ECTS)
Compulsory (9 ECTS):
- Microbiological diagnosis of infectious diseases. Phenotypic methods (3 ECTS)
- Microbiological diagnosis of infectious diseases. Genotypic methods (3ECTS)
- Antimicrobial chemotherapy and design of new drugs (3 ECTS)
Electives (12 ECTS, to choose from the following subjects):
- Syndromic diagnosis of infectious diseases
- Infections due to microorganisms with resistance to multiple antibiotics. Surveillance, molecular studies and control of hospital outbreaks.
- Microbiological surveillance of infectious diseases
- Diagnosis of infections in immunosuppressed patients
- Tuberculosis and other mycobacterial infections. Successes and challenges of the 21st century
- Emerging Parasitic Diseases in a Changing World
- Pathogenicity and antibiosis. Nanotechnology approach
Final Master's Project (18 ECTS):
The Master's degree will provide a research project for each student, which will be carried out at the facilities of the university departments and microbiology services involved in the programme.
More information at: http://mastermicrobiologia.com/index.php/es/
Total (60 ECTS).
The Final Master Project is the most distinctive part of this programme. It is an unpublished and personal work of the student. All projects have an experimental basis and develop a research question concrete enough to obtain results within 4-5 months. Research will be carried out in hospital or university facilities in which Master's degree faculty develop their activities, and will be directly supervised by a professor or a collaborator of the Master's degree programme.
The following are examples of projects developed in the past:
- Novel synthetic peptides against gram-positive bacteria
- Microcin J25: characterization of antimicrobial peptides
- Prevalence of azole resistance among Aspergillus spp. isolated from respiratory samples of Cystic Fibrosis patients attending a large Spanish reference center
- Validation of the combination of meropenem and colistin against extensively drug-resistant Pseudomonas aeruginosa
- Drug resistance of clinical isolates of Mycobacterium tuberculosis
- Study of genes involved in the formation of biofilm in hypermucoviscous strains of Klebsiella pneumoniae (magA- / magA +)
- Standardization of in vitro drug combinations in non-tuberculous mycobacteria strains: slowly growing mycobacteria (Mycobacterium avium and Mycobacterium intracellulare) and rapidly growing mycobacteria (Mycobacterium abscessus)
- Usefulness of PCR and subsequent sequencing of different genes for the diagnosis and characterization of cutaneous leishmaniasis
- Characterization of strains causing tegumentary Leishmaniasis in Bolivia
- Preliminary phenotypic characterization of the new H-NS paralog found in the enteroaggregative strain of E. coli 042
- Resistance to last-resort human antimicrobial agentsamong Enterobacteria recovered from Barcelona sewer rats
- Analysis by sequencing the whole genome of pneumococcal invasive disease caused by serotype 8
- Influenza virus monitoring in critically ill patients, in the 2017-18 season
- A tool for a fast, simple, comfortable and direct detection of beta-lactamases in clinical samples. BL-Detect Tool.
- Molecular epidemiology of Chlamydia trachomatis L1, L2, L3 infection
- Pathogenicity factors of Staphylococcus epidermidis isolated from healthy carriers compared to isolated strains of joint prosthesis infection (IPA)
- Dynamics of persistent colonization by Haemophilus influenzae in COPD patients and long term treatment with azythromycin
- Analysis of the microbial community structure of Drosophila melanogaster and the change in it under treatment with Nyaditum Resae® at different concentrations by phenotypic and genotypic methods
- Virological surveillance of enteroviruses related to hand, foot and mouth disease and herpangina at the primary care setting